Vanguard Group Inc Cognition Therapeutics Inc Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,242,554 shares of CGTX stock, worth $534,298. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,242,554
Previous 1,147,554
8.28%
Holding current value
$534,298
Previous $1.9 Million
69.33%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CGTX
# of Institutions
45Shares Held
6.58MCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$948,3120.02% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$215,0000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA324KShares$139,1660.0% of portfolio
-
Cm Management, LLC250KShares$107,5000.1% of portfolio
-
American Financial Group Inc205KShares$88,1500.04% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $9.77M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...